312 related articles for article (PubMed ID: 36766357)
21. Advances in Epigenetic Cancer Therapeutics.
Hillyar C; Rallis KS; Varghese J
Cureus; 2020 Nov; 12(11):e11725. PubMed ID: 33391954
[TBL] [Abstract][Full Text] [Related]
22. Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization.
Cascione L; Giudice L; Ferraresso S; Marconato L; Giannuzzi D; Napoli S; Bertoni F; Giugno R; Aresu L
Noncoding RNA; 2019 Sep; 5(3):. PubMed ID: 31546795
[TBL] [Abstract][Full Text] [Related]
23. Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T-cell lymphomas.
Azuma K; Ohmi A; Goto-Koshino Y; Tomiyasu H; Ohno K; Chambers JK; Uchida K; Namba H; Nagata M; Nagamine E; Nibe K; Irie M; Tsujimoto H
Vet Comp Oncol; 2022 Mar; 20(1):118-126. PubMed ID: 34250731
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
Milner RJ; Pearson J; Nesbit JW; Close P
Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics.
Fathi E; Farahzadi R; Montazersaheb S; Bagheri Y
Curr Gene Ther; 2021; 21(1):60-71. PubMed ID: 33183201
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of morphotypes in canine lymphomas: A systematic review of literature.
Sayag D; Fournel-Fleury C; Ponce F
Vet Comp Oncol; 2018 Mar; 16(1):12-19. PubMed ID: 28524622
[TBL] [Abstract][Full Text] [Related]
27. [Epigenetic abnormalities in non-Hodgkin lymphomas].
Furukawa Y
Rinsho Ketsueki; 2021; 62(9):1367-1381. PubMed ID: 34615796
[TBL] [Abstract][Full Text] [Related]
28. Cytodiagnostics of canine lymphomas - possibilities and limitations.
Sapierzyński R; Kliczkowska-Klarowicz K; Jankowska U; Jagielski D
Pol J Vet Sci; 2016; 19(2):433-9. PubMed ID: 27487521
[TBL] [Abstract][Full Text] [Related]
29. Outcome and Prognostic Factors for Canine Splenic Lymphoma Treated by Splenectomy (1995-2011).
van Stee LL; Boston SE; Singh A; Romanelli G; Rubio-Guzman A; Scase TJ
Vet Surg; 2015 Nov; 44(8):976-82. PubMed ID: 26426095
[TBL] [Abstract][Full Text] [Related]
30. Investigation of canine extracellular vesicles in diffuse large B-cell lymphomas.
Kulka M; Brennan K; Mc Gee M
PLoS One; 2022; 17(9):e0274261. PubMed ID: 36125986
[TBL] [Abstract][Full Text] [Related]
31. The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study.
Aricò A; Giantin M; Gelain ME; Riondato F; Comazzi S; Rütgen BC; Essler SE; Dacasto M; Castagnaro M; Aresu L
BMC Vet Res; 2013 May; 9():94. PubMed ID: 23641796
[TBL] [Abstract][Full Text] [Related]
32. The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.
Albonico F; Mortarino M; Avallone G; Gioia G; Comazzi S; Roccabianca P
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):117-23. PubMed ID: 23871213
[TBL] [Abstract][Full Text] [Related]
33. Prognostic efficacy of the human B-cell lymphoma prognostic genes in predicting disease-free survival (DFS) in the canine counterpart.
Zamani-Ahmadmahmudi M; Aghasharif S; Ilbeigi K
BMC Vet Res; 2017 Jan; 13(1):17. PubMed ID: 28069005
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
35. High content imaging for the morphometric diagnosis and immunophenotypic prognosis of canine lymphomas.
Papakonstantinou S; O'Brien PJ
Cytometry B Clin Cytom; 2014 Nov; 86(6):373-82. PubMed ID: 25044888
[TBL] [Abstract][Full Text] [Related]
36. The Current State of Clinical Application of Serum Biomarkers for Canine Lymphoma.
Bryan JN
Front Vet Sci; 2016; 3():87. PubMed ID: 27747218
[TBL] [Abstract][Full Text] [Related]
37. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
38. First meeting of the European canine lymphoma group. Workshop: state of the art and comparative aspects in canine lymphoma. CH-Lugano, 22 June 2013.
Comazzi S; Guscetti F; Marconato L
Hematol Oncol; 2014 Jun; 32(2):68-71. PubMed ID: 24193915
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of AgNOR counts and PCNA-positive cell counts in canine malignant lymphomas.
Kiupel M; Bostock D; Bergmann V
J Comp Pathol; 1998 Nov; 119(4):407-18. PubMed ID: 9839202
[TBL] [Abstract][Full Text] [Related]
40. Glycoproteomic profiling of serum peptides in canine lymphoma and transitional cell carcinoma.
Wilson CR; Regnier FE; Knapp DW; Raskin RE; Andrews DA; Hooser SB
Vet Comp Oncol; 2008 Sep; 6(3):171-81. PubMed ID: 19178677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
